Protein | Prolargin |
Gene | PRELP |
Status | Reviewed |
Source | Breast cancer xenografts; Breast tumor; Cerebrospinal fluid; Colorectal tumor; Liver; Ovarian tumor; Prostate; Prostate tumor; Serum; Urine |
Years | 2007-2015 |
Site | Identified Peptides | Year(Publication ID) |
---|---|---|
124 | SFQnATGLR | 2014(14); 2014(33); |
124 | ESFQnATGLR | 2012(3); |
124 | PVESFQnATGL | 2009(64); |
124 | VESFQnATGLR | 2014(14); 2014(33); 2015(unpublished); |
124 | PVESFQnATGLR | 2007(unpublished);2014(14); |
124 | ITELPVESFQnAT | 2014(33); |
124 | LPVESFQnATGLR | 2014(14); 2014(33); |
124 | ELPVESFQnATGLR | 2014(14); 2014(33); 2015(unpublished); |
124 | ITELPVESFQnATGL | 2014(33); |
124 | TELPVESFQnATGLR | 2014(14); |
124 | ITELPVESFQnATGLR | 2014(14); 2014(33); |
124 | FITELPVESFQnATGLR | 2014(14); 2014(33); 2015(unpublished); |
124 | ITELPVESFQnATGLRW | 2014(33); |
124 | NFITELPVESFQnATGLR | 2014(33); 2015(unpublished); |
124 | QNNFITELPVESFQnATGLR | 2014(33); |
124 | LQNNFITELPVESFQnATGLR | 2014(33); 2015(unpublished); |
124 | LYLQNNFITELPVESFQnATGL | 2014(33); |
124 | YLQNNFITELPVESFQnATGLR | 2014(33); |
124 | LYLQNNFITELPVESFQnATGLR | 2014(33); |
124 | IHYLYLQNNFITELPVESFQnATGLR | 2009(64); 2013(34); 2014(33); 2015(unpublished);2015(unpublished);2015(unpublished);2007(unpublished);2007;2007;2007; |
289 | NSFnISNL | 2014(14); 2015(unpublished); |
289 | NSFnISNLL | 2014(14); 2014(33); 2015(unpublished); |
289 | NSFnISNLLV | 2014(14); 2015(unpublished); |
289 | NSFnISNLLVL | 2014(14); 2015(unpublished); |
289 | NSFnISNLLVLH | 2014(33); 2015(unpublished); |
289 | NSFnISNLLVLHLSH | 2014(33); 2015(unpublished); |
289 | SFnISNLLVLHLSHNR | 2015(unpublished); |
289 | NSFnISNLLVLHLSHNR | 2014(33); 2015(unpublished);2015(unpublished);2007(unpublished);2007;2007; |
289 | GLPKNSFnISNLLVLHLSHNR | 2014(33); |
320 | YLNnNSIEK | 2014(14); |
320 | LNnNSIEKIN | 2014(33); |
320 | HLYLNnNSIEK | 2014(33); |
320 | LEHLYLNnNSIEK | 2014(14); 2014(22); 2014(33); 2015(unpublished);2015(unpublished);2015(unpublished); |
320 | NnNSIEKINGTQICPNDLVAF | 2014(33); |
320 | LNnNSIEKINGTQICPNDLVAF | 2014(33); |
320 | LNnNSIEKINGTQICPNDLVAFH | 2014(33); |
320 | LEHLYLNnNSIEKINGTQICPNDLVAFHDFSSDLENVPHLR | 2014(33); |
327 | IEKInGTQ | 2009(64); |
327 | InGTQICPN | 2014(33); |
327 | InGTQICPNDLVAF | 2014(33); |
327 | InGTQICPNDLVAFH | 2014(33); |
327 | KInGTQICPNDLVAF | 2014(33); |
327 | InGTQICPNDLVAFHDF | 2014(33); |
327 | SIEKInGTQICPNDLVAF | 2014(33); |
327 | NNNSIEKInGTQICPNDLVAF | 2014(33); |
327 | InGTQICPNDLVAFHDFSSDLE | 2014(33); |
327 | LNNNSIEKInGTQICPNDLVAF | 2014(33); |
327 | KInGTQICPNDLVAFHDFSSDLE | 2014(33); |
327 | LNNNSIEKInGTQICPNDLVAFH | 2014(33); |
327 | InGTQICPNDLVAFHDFSSDLENVPH | 2014(33); 2015(unpublished); |
327 | InGTQICPNDIVAFHDFSSDIENVPHIR | 2014(32); |
327 | InGTQICPNDLVAFHDFSSDLENVPHLR | 2009(64); 2013(34); 2014(33); 2015(unpublished);2015(unpublished);2007;2007; |
327 | LEHLYLNNNSIEKInGTQICPNDLVAFHDFSSDLENVPHLR | 2014(33); |
1 | 11 | 21 | 31 | 41 | 51 | 61 | 71 | 81 | 91 |
MRSPLCWLLP | LLILASVAQG | QPTRRPRPGT | GPGRRPRPRP | RPTPSFPQPD | EPAEPTDLPP | PLPPGPPSIF | PDCPRECYCP | PDFPSALYCD | SRNLRKVPVI |
101 | 111 | 121 | 131 | 141 | 151 | 161 | 171 | 181 | 191 |
PPRIHYLYLQ | NNFITELPVE | SFQNATGLRW | INLDNNRIRK | IDQRVLEKLP | GLVFLYMEKN | QLEEVPSALP | RNLEQLRLSQ | NHISRIPPGV | FSKLENLLLL |
201 | 211 | 221 | 231 | 241 | 251 | 261 | 271 | 281 | 291 |
DLQHNRLSDG | VFKPDTFHGL | KNLMQLNLAH | NILRKMPPRV | PTAIHQLYLD | SNKIETIPNG | YFKSFPNLAF | IRLNYNKLTD | RGLPKNSFNI | SNLLVLHLSH |
301 | 311 | 321 | 331 | 341 | 351 | 361 | 371 | 381 | |
NRISSVPAIN | NRLEHLYLNN | NSIEKINGTQ | ICPNDLVAFH | DFSSDLENVP | HLRYLRLDGN | YLKPPIPLDL | MMCFRLLQSV | VI |
ID | Publication |
---|---|
3 | Tian Y, Almaraz RT, Choi CH, Li QK, Saeui C, Li D, Shah P, Bhattacharya R, Yarema KJ, Zhang H: Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clinical proteomics 2015, 12:11. |
14 | Liu Y, Chen J, Sethi A, Li QK, Chen L, Collins B, Gillet LC, Wollscheid B, Zhang H, Aebersold R: Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Molecular & Cellular Proteomics 2014, 13:1753-1768. |
22 | Nicastri A, Gaspari M, Sacco R, Elia L, Gabriele C, Romano R, Rizzuto A, Cuda G: N-Glycoprotein Analysis Discovers New Up-Regulated Glycoproteins in Colorectal Cancer Tissue. Journal of Proteome Research 2014, 13:4932-4941. |
32 | Zhang Z, Sun Z, Zhu J, Liu J, Huang G, Ye M, Zou H: High-Throughput Determination of the Site-Specific N-Sialoglycan Occupancy Rates by Differential Oxidation of Glycoproteins Followed with Quantitative Glycoproteomics Analysis. Analytical Chemistry 2014, 86:9830-9837. |
33 | Zhu J, Sun Z, Cheng K, Chen R, Ye M, Xu B, Sun D, Wang L, Liu J, Wang F, Zou H: Comprehensive Mapping of Protein N-Glycosylation in Human Liver by Combining Hydrophilic Interaction Chromatography and Hydrazide Chemistry. Journal of Proteome Research 2014, 13:1713-1721. |
34 | Sun S, Zhang B, Aiyetan P, Zhou J-Y, Shah P, Yang W, Levine DA, Zhang Z, Chan DW, Zhang H: Analysis of N-glycoproteins using Genomic N-glycosite Prediction. Journal of Proteome Research 2013, 12:5609-5615. |
64 | Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res 2009, 8:651-661. |